WRAP Retail Offer

SkinBioTherapeutics plc (AIM:SBTX), a life science group focused on skin health, is pleased to announce a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £0.62m (the "WRAP Retail Offer") through the issue of new ordinary shares of 1p each in the capital of the Company ("Ordinary Shares"). Under the WRAP Retail Offer up to 3,617,647 new Ordinary Shares (the "WRAP Retail Offer Shares") will be made available at a price of 17 pence per share.

In addition to the WRAP Retail Offer and as announced at 7.00 a.m. today, the Company is also proposing a placing (the "Placing") and a subscription (the "Subscription") of 24,117,645 new Ordinary Shares (together the "Fundraising") to raise approximately £4.1m (gross) at a price of 17 pence per Ordinary Share (the "Placing Price"). The Placing Price represents no discount to the closing bid price of an Ordinary Share on 13 June 2005 (being the latest practicable date prior to this announcement). The issue price of the WRAP Retail Offer Shares is equal to the Placing Price.

A separate announcement has been made regarding the Fundraising and its terms and sets out the reasons for the Fundraising and use of proceeds. The proceeds of the WRAP Retail Offer will be utilised in the same way as the proceeds of the Fundraising.

For the avoidance of doubt, the WRAP Retail Offer is not part of the Fundraising. Completion of the WRAP Retail Offer is conditional, inter alia, upon the completion of the Fundraising but completion of the Fundraising is not conditional on the completion of the WRAP Retail Offer.

The WRAP Retail Offer and the Fundraising are conditional on the new Ordinary Shares being admitted to trading on AIM ("Admission"). It is anticipated that Admission for the new Ordinary Shares to be issued pursuant to the Fundraising will become effective and that dealings will commence on AIM, at 8.00 a.m. on 24 June 2025. It is further anticipated that Admission for the new Ordinary Shares to be issued pursuant to the WRAP Retail Offer will become effective and that dealings will commence on AIM, at 8.00 a.m. on 24 June 2025.

WRAP Retail Offer

Therefore, the Company is making the WRAP Retail Offer open to eligible investors in the United Kingdom, being existing shareholders of SkinBioTherapeutics through participating financial intermediaries.

The WRAP Retail Offer is expected to close at 16.30 p.m. on Thursday 19 June 2025. Eligible shareholders should note that financial intermediaries may have earlier closing times.

There is a minimum subscription of £100 per investor under the WRAP Retail Offer. The terms and conditions on which investors subscribe will be provided by the relevant financial intermediaries including relevant commission or fee charges.

It is a term of the WRAP Retail Offer that the total value of the WRAP Retail Offer Shares available for subscription at the Placing Price does not exceed £0.62m, or such size as agreed by the Company.

The Company's LEI is 213800YMQOCB23FX6I06